Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Cancer Therapy: Preclinical

5-Aza-2′-Deoxycytidine Delays Androgen-Independent Disease and Improves Survival in the Transgenic Adenocarcinoma of the Mouse Prostate Mouse Model of Prostate Cancer

Christoph S. Zorn, Kirk J. Wojno, Michael T. McCabe, Rainer Kuefer, Juergen E. Gschwend and Mark L. Day
Christoph S. Zorn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kirk J. Wojno
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael T. McCabe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rainer Kuefer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juergen E. Gschwend
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark L. Day
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1078-0432.CCR-06-2381 Published April 2007
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: April 2007 to February 2021

AbstractFull-text HTMLPDF
Total143327861542

Cited By

Article Information

Volume 13, Issue 7, pp. 2136-2143

DOI 
https://doi.org/10.1158/1078-0432.CCR-06-2381
PubMed 
17404097

Published By 
American Association for Cancer Research
Print ISSN 
1078-0432
Online ISSN 
1557-3265
History 
  • Accepted January 9, 2007
  • Received September 28, 2006
  • Revision received December 18, 2006
  • Published first April 2, 2007.

Copyright & Usage 
American Association for Cancer Research

Author Information

  1. Christoph S. Zorn1,4,
  2. Kirk J. Wojno1,
  3. Michael T. McCabe2,
  4. Rainer Kuefer3,
  5. Juergen E. Gschwend4 and
  6. Mark L. Day1
  1. Authors' Affiliations:1Department of Urology, University of Michigan, Ann Arbor, Michigan; 2Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia; 3Department of Urology, University of Ulm, Ulm, Germany; and 4Department of Urology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany
  1. Requests for reprints:
    Mark L. Day, Department of Urology, University of Michigan, 6219 CCGC, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0944. Phone: 734-763-9968; Fax: 1-734-647-9271; E-mail: mday{at}umich.edu.
View Full Text
PreviousNext
Back to top
Clinical Cancer Research: 13 (7)
April 2007
Volume 13, Issue 7
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
5-Aza-2′-Deoxycytidine Delays Androgen-Independent Disease and Improves Survival in the Transgenic Adenocarcinoma of the Mouse Prostate Mouse Model of Prostate Cancer
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
5-Aza-2′-Deoxycytidine Delays Androgen-Independent Disease and Improves Survival in the Transgenic Adenocarcinoma of the Mouse Prostate Mouse Model of Prostate Cancer
Christoph S. Zorn, Kirk J. Wojno, Michael T. McCabe, Rainer Kuefer, Juergen E. Gschwend and Mark L. Day
Clin Cancer Res April 1 2007 (13) (7) 2136-2143; DOI: 10.1158/1078-0432.CCR-06-2381

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
5-Aza-2′-Deoxycytidine Delays Androgen-Independent Disease and Improves Survival in the Transgenic Adenocarcinoma of the Mouse Prostate Mouse Model of Prostate Cancer
Christoph S. Zorn, Kirk J. Wojno, Michael T. McCabe, Rainer Kuefer, Juergen E. Gschwend and Mark L. Day
Clin Cancer Res April 1 2007 (13) (7) 2136-2143; DOI: 10.1158/1078-0432.CCR-06-2381
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results and Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • PK/PD Model of a Bispecific DART Molecule in Monkeys
  • STAT3/HOTAIR/EZH2 Regulates HNSCC Growth
  • TAZ is a Potent Mediator of aRMS Tumorigenesis
Show more Cancer Therapy: Preclinical
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement